In recognition of September as Blood Cancer Awareness Month, Andrew Jallouk, MD, assistant professor of medicine at Vanderbilt University, discusses the surge of approved therapies in lymphoma over ...

During a live event, Kit Yu Lu, MD, discussed data on antibody-drug conjugates in HR+, HER2- breast cancer including the ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic ...

Andrew Jallouk, MD, highlights the challenges in lymphoma treatment, including access disparities and the need for personalized therapies for better patient outcomes.

During a live event, Tian Zhang, MD, MHS, discussed darolutamide in mHSPC, with efficacy and cost being key considerations ...